CURRENT DRUG METABOLISM

Literals

• dcterms:coverage
  • 2000-2020
• bibo:issn
  • 1389-2002
• ou:categoriaSJR
  • Clinical Biochemistry (Q2)
  • Pharmacology (Q2)
• dcterms:identifier
  • 2014-6951
• ou:codigoRevista
  • 1389-2002
  • 1875-5453
• vcard:country-name
  • United Arab Emirates
• bibo:eissn
  • 1875-5453
• dcterms:publisher
  • Bentham Science Publishers B.V.
• vcard:region
  • Middle East
• ou:sjrMejorCuartil
  • Q2
• dcterms:title
  • CURRENT DRUG METABOLISM

Typed Literals

• ou:sjr
  • 1.014 (http://www.w3.org/2001/XMLSchema#Decimal)

Inverse Relations

• Has related: ou:publicadaEnRevista
  • Clinical use of biomarkers in drug metabolism and adverse drug reactions
  • Gene variants and haplotypes modifying transcription factor binding sites in the human cyclooxygenase 1 and 2 (PTGS1 and PTGS2) genes
  • Genomic and pharmacogenomic biomarkers of parkinson's disease
  • Incorporation of pharmacogenomics into routine clinical practice: The clinical pharmacogenetics implementation consortium (CPIC) guideline development process
  • Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in latin America